Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 19, 2015 3:53 PM ET

Biotechnology

Company Overview of Protagonist Therapeutics, Inc.

Company Overview

Protagonist Therapeutics, Inc. operates as a biotechnology company that engages in the discovery and development of ‘orally stable peptides’ against validated targets and diseases that are being addressed by ‘injectable biologics’. The company focuses on developing oral peptides for inflammatory bowel diseases (IBD), irritable bowel syndrome, and other gastro-intestinal disorders. Its development portfolio includes a4ß7 integrin specific ‘oral peptide’ antagonist for the treatment of IBD; IL-6 peptide antagonist, which is used in the treatment of various diseases, such as IBD, psoriasis, and rheumatoid arthritis; Hepcidin, a natural peptide hormone that regulates iron homeostasis and its def...

521 Cottonwood Drive

Suite 100

Milpitas, CA 95035-7404

United States

Founded in 2001

Phone:

408-649-7370

Key Executives for Protagonist Therapeutics, Inc.

Chief Executive Officer, President and Director
Founder and Vice President of Technology & Alliances
Senior Vice President of Corporate Development
Director of Chemistry
Research Fellow of Chemistry
Compensation as of Fiscal Year 2014.

Protagonist Therapeutics, Inc. Key Developments

Protagonist Therapeutics, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:00 PM

Protagonist Therapeutics, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:00 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.

Protagonist Therapeutics, Inc. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 through Mar-04-2015

Protagonist Therapeutics, Inc. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 through Mar-04-2015. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland. Presentation Date & Speakers: Mar-03-2015, Dinesh V. Patel, Chief Executive Officer, President and Director.

Protagonist Therapeutics, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 11:30 AM

Protagonist Therapeutics, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 11:30 AM. Venue: The Waldorf Astoria, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
SpectraGenetics, LLC United States
Bugworks Research Inc. United States
Advanced Pain Remedies, Inc. United States
Advanced Glaucoma Technologies, Inc. United States
MPS BioPharm United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Protagonist Therapeutics, Inc., please visit www.protagonist-inc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.